On the sidelines of the 78th session of the World Health Assembly in Geneva..
On the sidelines of the 78th session of the World Health Assembly in Geneva..
The Ministry of Health announces it will host a high-level event on rare diseases at its permanent mission to the United Nations
The Ministry of Health launches a live broadcast calling for fairer health policies on rare disease care
=========
The Ministry of Health and Population announced that it will host a high-level event entitled "From Invisible to Visible: Advancing the Global Health Agenda on Rare Disease Care and Innovation" at the permanent headquarters of the Egyptian Ministry of Health's mission to the United Nations in Geneva, on the sidelines of the 78th session of the World Health Assembly in the Swiss city of Geneva.
Dr. Hossam Abdel Ghaffar, official spokesperson for the Ministry of Health and Population, noted that the activities will include a live broadcast of the event on Monday at 7 p.m. Cairo time and 6 p.m. Central European Time, via the Ministry's official page on the social network Facebook.
Abdel Ghaffar explained that the event is in line with the joint Egyptian-Spanish draft resolution submitted to the World Health Assembly and sponsored by 28 countries, to highlight the importance of strengthening healthcare for patients with rare diseases, as well as working on drafting a global implementation plan that will serve as a roadmap for healthcare systems in confronting these diseases.
Abdel Ghaffar continued that the event is held within a distinguished partnership between the Arab Republic of Egypt and the Kingdom of Spain, and is sponsored by AstraZeneca and HVD, forming an international platform that highlights the care of more than 300 million people living with rare diseases around the world.
For his part, Dr. Mohamed Hassany, Assistant Minister of Health for Public Health Initiatives Projects, stressed the importance of the event in launching an international call aimed at setting fairer and more inclusive health policies, stimulating investment in scientific research and early diagnosis, and driving innovation in care and treatment, ensuring that no patient is left behind, however rare their health condition.